The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes
Authors:
- Neema JamshidiNJNeema Jamshidi
- Katharina von LöhneysenKLKatharina von Löhneysen
- Katrin SoldauKSKatrin Soldau
- Jeffrey S. FriedmanJFJeffrey S. Friedman
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (KL2TR001882)
- National Institutes of Health
- U.S. Army
- National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK075763)
- National Institute of Diabetes and Digestive and Kidney Diseases (RO1 DK080232)
- Army Research Office
This publication has 72 references indexed in Scilit:
- Peroxiredoxins in erythrocytes: far beyond the antioxidant roleJournal of Molecular Medicine, 2023
- Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug targetCell Reports, 2022
- Quantitative metabolomic analysis of changes in the lens and aqueous humor under development of age-related nuclear cataractMetabolomics, 2019
- Antioxidant and Membrane Binding Properties of Serotonin Protect Lipids from OxidationBiophysical Journal, 2017
- Systems biology of the human red blood cellBlood Cells, Molecules, and Diseases, 2006
- Regulation of intracellular creatine in erythrocytes and myoblasts: Influence of uraemia and inhibition of Na, K‐ATPaseCell Biochemistry and Function, 1994
- Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studiesAnnals of Hematology, 1991
- Determination of argininosuccinate lyase and arginase activities with an amino acid analyzerAnalytical Biochemistry, 1990
- In vivo aging of red cell enzymes: Study of biotinylated red blood cells in rabbitsAmerican Journal of Hematology, 1990
- Metabolic regulation and mathematical modelsProgress in Biophysics and Molecular Biology, 1978